Browse > Article
http://dx.doi.org/10.5142/JGR.2007.31.3.127

Perspectives for Ginsenosides in Models of Parkinson's Disease  

Wei-Ming, Lin (Yangling University)
Gille, Gabriele (Department of Neurology, Technical University)
Radad, Khaled (Department of Pathology, Faculty of Veterinary Medicine, Assiut University)
Rausch, Wolf-Dieter (Institute for Medical Chemistry, Veterinary Medical University)
Publication Information
Journal of Ginseng Research / v.31, no.3, 2007 , pp. 127-136 More about this Journal
Abstract
Ginseng, the root of Panax species, is a well-known herbal medicine. It has been used as traditional medicine in Korea, China and Japan for thousands of years and now is a popular and worldwide natural medicine. The active principles of ginseng are ginsenosides which are also called ginseng saponins. Traditionally ginseng has been used primarily as a tonic to invigorate weak body functions and help the restoration of homeostasis. Current in vivo and in vitro studies demonstrate its beneficial effects in a wide range of pathological conditions such as cardiovascular diseases, cancer, immune deficiency and hepatotoxicity. Moreover, recent research indicates that some of ginseng's active ingredients exert beneficial actions on aging and neurodegenerative disorders such as Parkinson´s disease. Essentially, antioxidant, antiinflammatory, anti-apoptotic and immunostimulant activities are mostly underlying the postulated ginseng-mediated protective mechanisms. Next to animal studies, data from neural cell cultures contribute to the understanding of these mechanisms which involve decreasing nitric oxide, scavenging of free radicals and counteracting excitotoxicity. This paper focuses on own and other neuroprotective data on ginseng for dopaminergic neurons and intends to show aspects where neuroprotection e.g. by ginsenosides, additionally or preceding standard Parkinson therapy, could come about as a valuable contribution to slow neurodegenerative processes.
Keywords
Ginsenosides; Parkinson's disease; dopaminergic; neuroprotection;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Paulus, W. and Jellinger, K.: The neuropathologic basis of different clinical subgroups of Parkinson's disease. J. Neuropathol. Exp. Neurol. 50, 743-755. (1991)   DOI
2 Shen, L. and Zhang, J.: Ginsenoside $Rb_1$ increases ischemia-induced cell proliferation and survival in the dentate gyrus of adult gerbils. Neurosci. Lett. 344, 1-4 (2003)   DOI   ScienceOn
3 Persson, J., Bringlov, E., Nilsson, L. G. and Nyberg, L.: The memory-enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers. Psychopharmacology 172, 430-434 (2004)   DOI
4 Yun, T. K.: Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16: 53-55 (2001)
5 Tsang, D., Yeung, H. W., Tso, W. W. and Peck, H.: Ginseng saponins: influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med. 3, 221-224 (1985)
6 Albin, R. L. and Greenamyre, J. T.: Alternative excitotoxic hypotheses. Neurology 42, 733-738 (1992)   DOI
7 Murer, M. G., Dziewczapolski, G., Menalled, L. B., Garcia, M. C., Agid, Y., Gershanik, O. and Raisman-Vozari, R.: Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Ann. Neurol. 43, 561-575 (1998)   DOI   ScienceOn
8 Lai, C. T. and Yu, P. H.: Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced ctoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells: Effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53, 363-372 (1997)   DOI   ScienceOn
9 Chu, G. X. and Chen, X.: Anti-lipid peroxidation and protection of ginsenosides against cerebral ischemia-reperfusion in rats. Zhongguo Yao Li Xue Bao 11, 119-123 (1990)
10 Sugaya, A., Yuzurihara, M., Tsuda, T., Yasuda, K., Kajiwara, K. and Sugaya, A. E.: Proliferative effect of ginseng saponin on neurite extension of primary cultured neurons of the rat cerebral cortex. J. Ethnopharmacol. 22,173-181(1988)   DOI   ScienceOn
11 Salim, K. N., McEven, B. S. and Choa, H. M.: Ginsenoside $Rg_1$ regulates ChAT, NGF and trkA mRNA expression in the rat brain. Brain Res. Mol. Brain Res. 47, 177-182 (1997)   DOI   ScienceOn
12 Sattler, R. and Tymiansky, M.: Molecular mechanism of calcium dependent excitotoxicity, J. Mol. Med. 78, 3-13 (2000)   DOI   ScienceOn
13 Radad, K., Gille, G., Moldzio, R., Saito, H. and Rausch, W. D.: Ginsenosides $Rb_1$ and $Rg_1$ effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021, 41-53 (2004)   DOI   ScienceOn
14 Itoh, T., Zang, Y. F., Murai, S. and Saito, H.: Effects of Panax ginseng root on the vertical and horizontal motor activities and on brain monoamine-related substances in mice. Planta Med. 55, 429-433 (1989)   DOI   ScienceOn
15 Quinn, N., Parkes, D., Janota, I. and Marsden, C. D.: Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Mov. Disord. 1, 65-68. (1986)   DOI   ScienceOn
16 Reichmann, H.: Long-term treatment with dopamine agonists in idiopathic Parkinson's disease. J. Neurol. 247 [Suppl 4], 17-19 (2000)   DOI   ScienceOn
17 Lipton, S. A. and Rosenberg, P. A.: Excitatory amino acids as a final common pathway for neurologic disorders. Engl. J. Med. 330, 613-622 (1994)   DOI   ScienceOn
18 Yamaguchi, Y., Higashi, M. and Kobayashi, H.: Effects of ginsenosides on impaired performance caused by scopolamine in rats. Eur. J. Pharmacol. 312,149-151 (1996)   DOI   ScienceOn
19 Wen, T. C., Yoshimura, H., Matsuda, S., Lim, J. H. and Sakanaka, M.: Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol. 91, 15-22 (1996)   DOI
20 Radad, K., Gille, G. Moldzio R., Saito, H, Ishige K. and Rausch, W. D.: Ginsenosides $Rb_1\;and\;Rg_1$ effects on survival and neurite growth of $MPP^+$ -affected mesencephalic cells. J. Neural Transm. 111, 37-45 (2004)   DOI   ScienceOn
21 Olanow, C. W.: A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444 (1993)   DOI   ScienceOn
22 Jenner, P., Schapira, A. H. and Marsden, C. D.: New insights into the cause of Parkinson's disease. Neurology 42, 2241-2250 (1992)   DOI
23 Yuan, H., Sarre, S., Ebinger, G. and Michotte, Y.: Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Brain Res. 1026, 95-107 (2004)   DOI   ScienceOn
24 Metman, L. V., Konitsiotis, S. and Chase, T. N.: Pathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what. Mov. Disord. 15, 3-8 (2000)   DOI   ScienceOn
25 Ling, Z. D., Pieri, S. C. and Carvey, P. M.: Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons. Clin. Neuropharmacol. 19, 360-365 (1996)   DOI   ScienceOn
26 Mytilineou, C., Han, S. K. and Cohen, G.: Toxic and protective effects of L-dopa on mesencephalic cell cultures. J. Neurochem. 61, 1470-1478 (1993)   DOI
27 Ferrario, J. E., Delfino, M. A., Stefano, A. V., Zbarsky, V., Douhou, A., Murer, M. G., Raisman-Vozari, R. and Gershanik, O. S.: Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process. Neurosc.i Res. 47, 431-436 (2003)   DOI   ScienceOn
28 Spina, M. B. and Cohen, G.: Exposure of striatal synaptosomes to L-dopa increases levels of oxidized glutathione. J. Pharmacol. Exp. Ther. 247, 502-507 (1988)
29 Birkmayer, W. and Hornykiewicz, O.: The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism.. Wien. Klin. Wochenschr. 113, 851-854 (1961)
30 Chase, T. N., Mouradian, M. M. and Engber, T. M.: Motor response complications and the function of striatal efferent systems. Neurology 4, 23-27 (1993)
31 Nutt, J. G.: Clinical pharmacology of levodopa-induced dyskinesia. Ann. Neurol. 47, 160-164 (2000)
32 Kebabian, J. W. and Calne, D. B.: Multiple receptors for dopamine. Nature 277, 93-96 (1979)   DOI   ScienceOn
33 Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. and Caron, M. G.: Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225 (1998)   DOI
34 Sokoloff, P. and Schwartz, J. C.: Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16, 270-275 (1995)   DOI   ScienceOn
35 Zigmond, M. J., Hastings, T. G. and Perez, R. G.: Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? Parkinsonism Rel. Disord. 8, 389-393 (2002)   DOI   ScienceOn
36 Foley, P., Gerlach, M., Double, K. L. and Riederer, P.: Dopamine receptor agonists in the therapy of Parkinson's disease. J. Neural Transm. 111, 1375-1446 (2004)   DOI   ScienceOn
37 Hefti, F., Melamed, E., Bhawan, J. and Wurtman, R.: Long-term administration of L.dopa does not damage dopaminergic neurons in the mouse. Neurology 31, 1194-1195 (1981)   DOI
38 Perry, T. L., Yong, V. W., Ito, M., Foulks, J. G., Wall, R. A., Godin, D. V. and Clavier, R. M.: Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J. Neurochem. 43, 990-993 (1984)   DOI
39 Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, M. and Kakizaki, A.: Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369, 23-32. (1999)   DOI   ScienceOn
40 Blumenthal, M.: Asian ginseng: potential therapeutic uses. Adv. Nurse Pract. 2, 26-28 (2001)
41 Pardo, B., Mena, M. A. and de Yebenes, J. G.: L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells. J. Neurochem. 64, 576-582 (1995)   DOI   ScienceOn
42 Pedros, R. and Soares-da-Silva, P.: Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br. J. Pharmacol. 137, 1305-1313 (2002)   DOI   ScienceOn
43 Rhim, H., Kim, H., Lee, D. Y., Oh, T. H. and Nah, S. Y.: Ginseng and ginsenoside Rg3, a newly identical active ingredient of ginseng, modulate $Ca^{2+}$ channel currents in rat sensory neurons. Eur. J. Pharmacol. 463, 151-158 (2002)
44 Muriel, M. P., Bernard, V., Levey, A. I., Laribi, O., Abrous, D. N., Agid, Y., Bloch, B. and Hirsch, E. C.: Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann. Neurol. 46, 103-111 (1999)   DOI   ScienceOn
45 Muriel, M. P., Orieux, G. and Hirsch, E. C.: Levodopa but not ropinirole induces and internalization of D1 dopamine receptors in parkinsonian rats. Mov. Disord. 17, 1174-1179 (2002)   DOI   ScienceOn
46 Noverino, E., Amato, M. and Izzo, A. A.: The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 71: 1-5 (2000)   DOI   ScienceOn
47 Wen, T. C., Yoshimura, H., Matsuda, S., Lim, J. H. and Sakanaka, M.: Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol. 91, 15-22 (1996)   DOI
48 Lim, J. H., Wen, T. C., Matsuda, S., Tanaka, J., Maeda, N., Peng, H., Aburaya, J., Ishihara, K. and Sakanaka, M.: Protection of ischaemic hippocampal neurons by ginsenosides $Rb_1$, a main ingredient of ginseng root. Neurosci. Res. 28, 191-200 (1997)   DOI   ScienceOn
49 Liu, C. X. and Xiao, P. G.: Recent advances on ginseng research in China. J. Ethnopharmacol. 36, 27-38 (1992)   DOI   ScienceOn
50 Jenner, P.: Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease. Curr. Opin. Neurol. 16, 3-7 (2003)
51 Pirtosek, Z. and Flisar, D.: Neuroprotection and dopamine agonists. Adv. Exp. Med. Biol. 541, 55-74 (2004)
52 Gille, G., Rausch, W. D., Hung, S. T., Moldzio, R., Janetzky, B., Hundemer, H. P., Kolter, T. and Reichmann, H.: Pergolide protects dopaminergic neurons in primary culture under stress conditions. J. Neural Transm. 109, 633-643 (2002)   DOI   ScienceOn
53 Bonuccelli, U.: Comparing dopamine agonists in Parkinson's disease. Curr. Opin. Neurol. 16, 13-19 (2003)   DOI   ScienceOn
54 Le, W. D. and Jankovic, J.: Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Ageing 18, 389-296 (2001)   DOI   ScienceOn
55 Rudakewich, M., Ba, F. and Benishin, C. G.: Neurotrophic and neuroprotective actions of ginsenosides $Rb_1$ and $Rg_1$. Planta Med . 67, 533-537 (2001)   DOI   ScienceOn
56 Kim, H. S., Zhang, Y. H., Fang, L. H. and Lee, M. K.: Effects of ginsenosides on bovine adrenal tyrosine hydroxylase. J. Ethnopharmacol. 66, 107-111 (1999)   DOI   ScienceOn
57 Bliss, T. V. and Collingridge, G. L.: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39 (1993)   DOI   ScienceOn
58 Tyler, V. E.: The Honest Herbal-A Sensible Guide to the Use of Herbs and Related Remedies. Third ed. The Haworth Press, New York (1993)
59 O'Hara, M., Kiefer, D., Farrell, K. and Kemper K.: A review of 12 commonly used medicinal herbs. Arch Fam Med 7, 523-536 (1998)   DOI   ScienceOn
60 Himi, T., Saito, H. and Nishiyama, N.: Effects of ginseng saponins on the survival of cerebral cortex neurons in cell cultures. Chem. Pharm. Bull. (Tokyo) 37, 481-484 (1989)   DOI   ScienceOn
61 Van Kampen, J., Robertson, H., Hagg, T. and Drobitch, R.: Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp. Neurol. 184, 21-29 (2003)
62 Mizumaki, Y., Kurimoto, M., Hirashima, Y., Nishijima, M., Kamiyama, H., Nagai, S., Takaku, A., Sugihara, K., Shimizu, M. and Endo, S.: Lipophilic fraction of Panax ginseng induces neuronal differentiation of PC12 cells and promotes neuronal survival of rat cortical neurons by protein kinase C dependent manner. Brain Res. 20, 254-260 (2002)
63 Kim, Y. C., Kim, S. R., Markelonis, G. J. and Oh, T. H.: Ginsenosides $Rb_1\;and\;Rg_3$ protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res. 4, 426-432 (1998)
64 Benishin, C. G.: Actions of ginsenoside $Rb_1$ on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21, 1-5 (1992)   DOI   ScienceOn
65 Chun, C. X., Gui, Z. Y., An, Z. L., Chun, H., Ying, C., Min, C. L., Fang, F., Can, Z. Y. and Hui, Z. C.: Ginsenoside $Rg_1$ attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur. J. Pharmacol. 473, 1-7 (2003)   DOI   ScienceOn
66 Kim, E. H., Jang, M. H., Shin, M. C., Shin, M. S. and Kim, C. J.: Protective effect of aqueous extract of Ginseng radix against 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 cells. Biol. Pharm. Bull. 26, 1668-1673 (2003)   DOI   ScienceOn
67 Chen, X. C., Chen, Y., Zhu, Y. G., Fang, F. and Chen, L. M.: Protective effect of ginsenoside $Rg_1$ against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol. Sin. 23, 829-834 (2002)
68 Rodriguez, M. C., Obeso, J. A. and Olanow, C. W.: Subthalamic nucleus mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44, 175-188 (1998)   DOI
69 Malenka, R. C. and Nicoll R. A.: NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanism. Trends Neurosci. 16, 521-527 (1993)   DOI   ScienceOn
70 Kim, H. S., Hong, Y. T., Oh, K. W., Seong, Y. H., Rheu, H. M. and Cho, D. H.: Inhibition by ginsenosides $Rb_1$ and $Rg_1$ of methamphetamine-induced hypersensitivity, conditioned place preference and post-synaptic dopamine receptor supersensitivity on mice. Gen. Pharmacol. 30, 783-789 (1998)   DOI   ScienceOn
71 Plaitakis, A. and Shashidharan, P.: Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247. 1125-1135 (2000)
72 Said, S. I., Pakbaz, H., Berisha, H. I. and Raza, S.: NMDA receptor activation: critical role in oxidant tissue injury. Free Radic. Bio. Med. 28, 1300-1302 (2000)   DOI   ScienceOn
73 Doble, A.: The role of excitotoxicity in neurodegenerative disese: implication for therapy. Pharmacol. Ther. 81, 163-221 (1999)   DOI   ScienceOn
74 Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T. and Kagawa, Y.: Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455 (1989)   DOI   ScienceOn
75 Mook-Jung, I., Hong, H. S., Boo, J. H., Lee, K. H., Yun, S. H., Cheong, M. Y., Joo, I., Huh, K. and Jung, M. W.: Ginsenoside $Rb_1$ and $Rg_1$ improve spatial learning and increase hippocampal synaptophysin level in mice. J. Neurosci. Res. 63, 509-915 (2001)   DOI   ScienceOn
76 Terasawa, K., Shimada, Y. and Kita, T.: Choto-san in the treatment of vascular dementia: a double blind, placebo-controlled study. Phytomedicine 4,15-22 (1997)   DOI   ScienceOn
77 Kim, H. S., Kang, J. G., Seong, Y. H., Nam, K. Y. and Oh, K. W.: Blockade by ginseng total saponins of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 50, 23-27 (1995)   DOI   ScienceOn
78 Kurimoto, H., Nishijo, H., Uwano, T., Yamaguchi, H., Zhong, Y. M., Kawanishi, K. and Ono, T.: Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats. Physiol. Behav. 82,345-355 (2004)   DOI   ScienceOn
79 D'Angelo, L., Grimaldi, R., Caravaggi, M., Marcoli, M., Perucca, E., Lecchini, S., Frigo, G.M. and Crema, A.: A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J. Ethnopharmacol. 16, 15-22 (1986)   DOI   ScienceOn
80 Kim, H. S., Kang, J. G., Seong, Y. H., Nam, K. Y. and Oh, K. W.: Blockade by ginseng total saponins of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 50, 23-27 (1995)   DOI   ScienceOn
81 Gerlach, M., Double, K., Arzberger, T., Leblhuber, F., Tatschner, T. and Riederer, P.: Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J. Neural Transm. 110, 1119-1127 (2003)   DOI   ScienceOn
82 Kennedy, D. O. and Scholey, A. B.: Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol. Biochem. Behav. 75, 687-700 (2003)   DOI   ScienceOn
83 Fahn, S. and Cohen, G.: the oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32, 804-812 (1992)   DOI   ScienceOn
84 Sala, F., Mulet, J., Choi, S., Jung, S. Y., Nah, S. Y., Rhim, H., Valor, L. M., Criado, M. and Sala, S.: Effects of ginsenoside $Rg_2$ on human neuronal nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 301, 1052-1059 (2002)   DOI   ScienceOn
85 Dziewczapolski, G., Murer, G., Agid Y., Gershanik, O. and Raisman-Vozari, R.: Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats. Neuroreport 8, 975-979 (1997)   DOI   ScienceOn
86 Shim, I., Won, J., Song, J., Kim, S. E. and Huh, S.: Modulatory effect of ginseng total saponins on dopamine release and tyrosine hydroxylase gene expression induced by nicotine in the mouse. J. Ethnopharmacol. 70, 161-169 (2000)   DOI   ScienceOn
87 Petkov, V.: Effect of ginseng on the brain biogenic monoamines and 3',5'-AMP system. Experiments on rats. Arzneimittelforschung 28, 388-393 (1978)
88 Kimura, T., Saunders, P. A., Kim, H. S., Rheu, H. M., Oh, K. W. and Ho, I. K.: Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. Gen. Pharmacol. 25, 193-199 (1994)   DOI   ScienceOn
89 Choi, S. E., Choi, S., Lee, J. H., Whiting, P. J., Lee, S. M. and Nah, S. Y.: Effects of ginsenosides on GABA(A) receptor channels expressed in Xenopus oocytes. Arch. Pharm. Res. 26, 28-33 (2003)   DOI   ScienceOn
90 Kim, H. S., Kang, J. G. and Oh, K. W.: Inhibition by ginseng total saponins of the development of morphine reverse tolerance and dopamine receptor supersensitivity in mice. Gen. Pharmacol. 26,1071-1076 (1995)   DOI   ScienceOn
91 Wang, A., Cao, Y., Wang, Y., Zhao, R. and Liu, C.: Effects of Chinese ginseng root and stem-leaf saponins on learning, memory and biogenic monoamines of brain in rats. Zhongguo Zhong Yao Za Zhi 20, 493-495 (1995)